CVE-2025-2289: The Zegen - Church WordPress Theme theme for WordPress is vulnerable to unauthorized access due to a missing c
CVE-2025-2289 is a medium-severity flaw (CVSS 4.3) affecting zegen. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
The Zegen - Church WordPress Theme theme for WordPress is vulnerable to unauthorized access due to a missing capability check on several AJAX endpoints in all versions up to, and including, 1.1.9. This makes it possible for authenticated attackers, with Subscriber-level access and above, to import, export, and update theme options.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 4.3 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.3% (top 79%) |
| CISA exploited list | No |
| Weakness | CWE-862 |
| Published | 2025-03-14 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2025-2289?
zegen: upgrade to newer than 1.1.9. Exact commands for each OS are on this page.
Is CVE-2025-2289 being exploited?
CVE-2025-2289 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2025-2289 affect?
CVE-2025-2289 affects zegen. Severity is medium (CVSS 4.3). The Zegen - Church WordPress Theme theme for WordPress is vulnerable to unauthorized access due to a missing capability check on several AJAX endpoints in all versions up to, and including, 1.1.9. This makes it possible for authenticated at
How urgent is CVE-2025-2289?
Priority 20/100. No elevated risk signals yet.